- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Proteins: Structure, Function, and Bioinformatics 91.11 (2023). DOI:10.1002/prot.26543
In: Proteins: Structure, Function, and Bioinformatics 91 : 11 John Wiley & Sons, Inc., 2023-07-05 - S. 1496-1509
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2023
- Creator
-
Chen, Xiyu
Leyendecker, Sigrid
van den Bedem, Henry
- DOI
-
10.1002/prot.26543
- URN
-
urn:nbn:de:101:1-2024030104074297837961
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:47 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Xiyu
- Leyendecker, Sigrid
- van den Bedem, Henry
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2023
Other Objects (12)
Structure-activity relationships of benzamides and isoindolines designed as SARS-CoV protease inhibitors effective against SARS-CoV-2
Discovery and characterization of protease inhibitors that block SARS-CoV-2 infection
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
SARS-CoV-2-Arbeitsschutzstandard
Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease
Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
SARS-CoV-2 und Medikamenten
Coronavirus - COVID-19 - SARS-COV-2
Structure-activity relationships of benzamides and isoindolines designed as SARS-CoV protease inhibitors effective against SARS-CoV-2
Discovery and characterization of protease inhibitors that block SARS-CoV-2 infection
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
SARS-CoV-2-Arbeitsschutzstandard
Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease
Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
SARS-CoV-2 und Medikamenten
Coronavirus - COVID-19 - SARS-COV-2
Structure-activity relationships of benzamides and isoindolines designed as SARS-CoV protease inhibitors effective against SARS-CoV-2
Discovery and characterization of protease inhibitors that block SARS-CoV-2 infection
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
SARS-CoV-2-Arbeitsschutzstandard
Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease
Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
SARS-CoV-2 und Medikamenten